GIM
RXST icon

Granahan Investment Management’s RxSight RXST Stock Holding History

Granahan Investment Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-129,721
Closed -$3.28M – 172
2025
Q1 		$3.28M Buy
129,721
+9,488
+8% +$282K 0.16% 117
2024
Q4 		$4.13M Buy
120,233
+187
+0.2% +$8.43K 0.17% 118
2024
Q3 		$5.93M Buy
120,046
+25,955
+28% +$1.33M 0.23% 110
2024
Q2 		$5.66M Buy
94,091
+77,061
+453% +$4.4M 0.23% 119
2024
Q1 		$878K Buy
+17,030
New +$836K 0.03% 172

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Granahan Investment Management's RXST Position: Q2 2025 in Review

Granahan Investment Management sold out of RxSight (RXST) in Q2 2025, closing a stake of 129,721 shares — an estimated $3.28M sold.

Granahan Investment Management first reported a position in RXST in Q1 2024 and held it in 5 quarters. The position peaked at $5.93M in Q3 2024. 174 funds tracked by Wall St. Rank hold RXST as of Q2 2025.

  • Granahan Investment Management reported no remaining RxSight position as of Q2 2025 after selling out during the quarter.
  • Granahan Investment Management sold 129,721 RxSight shares in Q2 2025, an estimated $3.28M.
  • Granahan Investment Management first reported a position in RxSight in Q1 2024 and held it in 5 quarters.
  • Granahan Investment Management's RxSight position peaked at $5.93M in Q3 2024.
  • 174 funds tracked by Wall St. Rank held RxSight as of Q2 2025.

Based on Granahan Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.